Named on 2 rounds in the feed.
Rounds from 2021-06-16 to 2022-01-06
ROUNDS
2
joined, none as lead
ROUNDS JOINED · USD
$583.8M
across 2 rounds
CO-INVESTORS
21
most often with The Column Group
Named on 2 rounds in the feed.
Rounds from 2021-06-16 to 2022-01-06
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Eikon Therapeutics Eikon is a late-stage clinical biopharmaceutical company focused on inventing and developing breakthrough therapeutics for serious illnesses through innovative scientific and engineering approaches. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $517.8M | 2022-01-06 | [ PART ] |
Circle Pharma A biopharmaceutical company advancing CID-165 for ER-positive breast cancer | Series C Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $66M | 2021-06-16 | [ PART ] |